Lenvatinib plus EGFR inhibition for liver cancer
Nat Rev Gastroenterol Hepatol
.
2021 Oct;18(10):675.
doi: 10.1038/s41575-021-00513-6.
Author
Jordan Hindson
1
Affiliation
1
Nature Reviews Gastroenterology & Hepatology, . nrgasthep@nature.com.
PMID:
34404918
DOI:
10.1038/s41575-021-00513-6
No abstract available
Publication types
Comment
MeSH terms
ErbB Receptors
Humans
Liver Neoplasms* / drug therapy
Phenylurea Compounds / therapeutic use
Quinolines* / therapeutic use
Substances
Phenylurea Compounds
Quinolines
EGFR protein, human
ErbB Receptors
lenvatinib